children
rang
age
year
recruit
prospect
larg
outpati
popul
univers
children
hospit
belgrad
januari
decemb
histori
reaction
bl
children
parent
complet
standard
questionnair
exclus
criteria
consist
sever
compromis
cardiovascular
renal
respiratori
function
studi
approv
hospit
ethic
committe
prior
studi
parent
children
receiv
inform
possibl
risk
skin
challeng
test
written
inform
consent
obtain
children
underw
skin
test
patch
test
accord
enda
guidelin
first
day
carri
skin
prick
intraderm
test
use
ppl
diater
madrid
spain
minor
determin
mixtur
mdm
diater
benzylpenicillin
patch
test
also
administ
benzylpenicillin
ampicillin
amoxicillin
suspect
bl
petrolatum
previous
describ
reagent
appli
uninvolv
skin
interscapular
region
children
back
use
acryl
adhes
strip
small
plate
attach
test
allergen
curatest
lohmann
rauscher
intern
gmbh
co
kg
rengsdorf
germani
occlus
time
h
read
made
recommend
brockow
et
al
min
remov
strip
h
later
two
day
later
ampicillin
amoxicillin
concentr
mgml
dilut
normal
salin
well
suspect
bl
use
prick
intraderm
test
evalu
first
subject
modifi
skin
test
protocol
perform
intraderm
test
suspect
bl
highest
concentr
indic
parenthes
benzylpenicillin
phenoxymethylpenicillin
iuml
ampicillin
amoxicillin
mgml
cephalexin
ceftriaxon
cefprozil
cefixim
ceftibuten
cefaclor
cefotaxim
cefuroxim
mgml
inject
drug
use
intraven
form
one
prepar
solut
previous
describ
reagent
freshli
prepar
everi
day
steril
condit
ml
reagent
solut
inject
intraderm
volar
forearm
skin
read
made
min
h
inject
late
reaction
intraderm
test
consid
posit
infiltr
erythema
appear
diamet
larger
mm
posit
control
perform
histamin
mgml
neg
one
normal
salin
accord
indic
contraind
enda
posit
paper
control
administr
therapeut
dose
suspect
drug
also
perform
children
display
neg
result
allergi
test
hospit
administ
initi
dose
therapeut
one
depend
children
weight
case
neg
result
h
later
administ
dose
result
neg
anoth
hour
full
dose
good
toler
occur
therapeut
cours
full
dose
given
day
afterward
home
sinc
june
public
studi
caubet
et
al
modifi
allergi
reduc
durat
therapeut
cours
home
day
children
parent
children
advis
stop
treatment
take
therapi
antihistamin
call
physician
experienc
reaction
perform
also
serolog
screen
viral
mycoplasma
pneumonia
infect
children
blood
drawn
perform
assay
antibodi
virus
known
associ
childhood
skin
rash
urticaria
parvoviru
adenoviru
herp
viru
mycoplasma
pneumonia
children
posit
igm
antibodi
mycoplasma
pneumonia
also
throat
swab
mycoplasma
screen
pcr
total
subject
histori
reaction
bl
antibiot
tabl
none
met
exclus
criteria
subject
report
total
reaction
penicillin
cephalosporin
respons
bl
clinic
manifest
shown
tabl
nine
hundr
children
report
hypersensit
reaction
one
drug
penicillin
cephalosporin
children
react
two
drug
penicillin
cephalosporin
penicillin
cephalosporin
children
react
three
drug
two
differ
penicillin
cephalosporin
children
present
total
posit
intraderm
test
children
also
posit
patch
test
tabl
four
subject
posit
intraderm
test
benzylpenicillin
amoxicillin
nineteen
children
posit
dpt
amoxicillin
benzylpenicillin
ampicillin
ceftriaxon
cephalexin
cefprozil
cefixim
case
observ
reaction
similar
ident
report
histori
urticaria
three
urticaria
angioedema
three
maculopapular
exanthema
one
subject
display
posit
patch
test
penicillin
posit
dpt
ceftriaxon
six
reaction
induc
dpt
perform
hospit
reaction
occur
children
back
home
thirteen
reaction
report
therapeut
cours
home
three
children
continu
therapi
day
home
median
time
interv
respons
dpt
h
h
last
dose
drug
reaction
usual
mild
control
corticosteroid
antihistamin
comparison
time
interv
respons
record
clinic
histori
show
signific
differ
six
children
posit
two
culprit
drug
two
posit
two
cephalosporin
four
penicillin
cephalosporin
present
tabl
overal
hypersensit
diagnos
children
basi
posit
respons
patch
test
andor
intraderm
test
provoc
test
culprit
bl
tabl
comparison
hypersensit
identifi
present
tabl
children
underw
serolog
screen
infecti
agent
posit
two
also
posit
allergi
result
test
present
tabl
studi
diagnos
delay
hypersensit
children
histori
reaction
bl
data
agreement
studi
perform
children
histori
hypersensit
reaction
bl
rule
hypersensit
major
subject
therefor
crucial
make
precis
diagnosi
overdiagnosi
bl
allergi
major
public
health
problem
result
use
altern
antibiot
increas
health
cost
bacteri
resist
regard
children
neg
result
allergi
test
includ
dpt
result
seem
indic
cutan
erupt
associ
bl
hypersensit
reaction
rather
manifest
underli
infecti
diseas
particularli
affect
respiratori
urinari
tract
antibiot
prescrib
reaction
includ
urticari
maculopapular
erupt
may
result
interact
virus
antibiot
fact
mani
hypersensit
reaction
drug
stimul
immun
system
virus
viru
hiv
lead
reaction
infect
individu
literatur
data
indic
maculopapular
exanthema
occur
hypersensit
reaction
bl
reaction
confus
viral
infect
viral
infect
common
caus
maculopapular
rash
urticaria
independ
taken
drug
caubet
et
al
show
children
least
posit
viral
studi
picornaviru
coronaviru
bocaviru
hmpv
influenza
parainfluenza
respiratori
syncyti
viru
ebv
parvoviru
cmv
group
neg
oral
provoc
test
opt
children
posit
opt
find
suggest
acut
ebv
recent
ebv
infect
found
children
posit
studi
infecti
agent
two
posit
allergi
acut
mycoplasma
pneumonia
infect
indentifi
children
posit
allergi
adenoviru
ebv
children
parvoviru
one
respect
children
therefor
urticaria
maculopapular
rash
due
underli
infect
hypersensit
reaction
bl
consid
specif
test
distinguish
viral
infect
hypersensit
reaction
drug
acut
phase
diagnost
perform
children
suspicion
drug
hypersensit
ideal
month
later
regard
diagnost
valu
allergi
test
reaction
bl
two
largest
studi
evalu
children
histori
reaction
intraderm
test
posit
children
respect
wherea
dpt
posit
studi
caubet
et
al
children
mild
erupt
associ
bl
therapi
evalu
skin
test
patch
test
dpt
children
underw
dpt
react
intraderm
test
posit
intraderm
test
neg
sensit
intraderm
test
specif
children
need
undergo
skin
test
identifi
patient
bl
hypersensit
base
result
take
also
account
result
studi
author
believ
dpt
administ
one
dose
follow
standard
dose
h
home
safe
effici
diagnost
procedur
found
posit
intraderm
test
higher
aforement
larg
studi
higher
rate
might
due
differ
sampl
assess
protocol
use
exampl
perform
intraderm
test
also
bl
cephalexin
cefaclor
cefprozil
cefixim
ceftibuten
phenoxymethylpenicillin
concentr
use
cephalosporin
cephalexin
cefaclor
cefprozil
ceftibuten
prove
previou
studi
perform
adult
children
lower
highest
mgml
suggest
recent
posit
paper
enda
far
protocol
skin
test
concern
consid
first
subject
observ
posit
respons
intraderm
test
suspect
bl
modifi
protocol
perform
test
suspect
bl
highest
concentr
regard
four
subject
posit
intraderm
test
consid
parent
provid
precis
descript
begin
reaction
last
dose
culprit
drug
usual
given
night
therefor
time
interv
reaction
exposur
clear
histori
children
evalu
accord
diagnost
algorithm
includ
skin
test
well
dpt
also
includ
patch
test
allergi
howev
children
display
posit
result
therefor
confirm
intraderm
test
sensit
patch
test
nineteen
children
posit
reaction
dpt
opt
parenter
provoc
test
data
confirm
dpt
protocol
safe
accur
diagnosi
concern
drug
involv
confirm
reaction
amoxicillin
ceftriaxon
interest
note
present
studi
posit
vivo
test
two
time
frequent
children
histori
reaction
one
bl
children
compar
react
one
bl
therefor
histori
reaction
one
bl
seem
indic
delay
hypersensit
conclus
studi
demonstr
children
confirm
hypersensit
reaction
bl
hypersensit
diagnos
children
basi
posit
respons
intraderm
test
consid
data
fact
studi
caubet
et
al
children
posit
intraderm
test
higher
rate
posit
dpt
without
posit
test
p
believ
still
advis
perform
intraderm
test
suspect
bl
highest
concentr
case
neg
result
dpt
fact
approach
would
allow
physician
diagnos
skin
test
patient
true
delay
hypersensit
thu
reduc
risk
posit
dpt
consid
result
present
studi
patch
test
indic
subject
mild
reaction
bl
maculopapular
urticari
rash
